3,3-DPCB

WARNING: NO HUMAN USE DATA EXISTS. This compound has never been documented as being used by humans recreationally or therapeutically. All information is extrapolated from a single 1978 animal study. The cyclobutane ring structure may undergo unpredictable metabolic ring-opening producing unknown metabolites. Animal studies showed locomotor stimulation only partially blocked by dopamine antagonists, suggesting mixed reuptake inhibition and monoamine release.

Also known as: DPCB

Classification

Psychoactive: Stimulant
Tag: Habit-Forming
Tag: Other stimulant
Tag: Research-Chemical

Effects

Stimulation
Loss Of Appetite
Teeth Grinding
Jaw Tension
Tachycardia
Insomnia
Increased Motivation
Euphoria
Anxiety
Talkativeness
Alertness Enhancement
Light Sensitivity

Routes of Administration

Oral

Dosage

Heavy: 50 mg+ (unknown safety; avoid)
Light: 10–20 mg
Common: 20–35 mg
Strong: 35–50 mg
Threshold: 5–10 mg (extrapolative)

Duration

Onset: 0.33-1 h
Peak: 1-3 h
Offset: 3-8 h
After Effects: 8-24 h
Total Duration: 4-8 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

dose.wiki

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu